Taken together, these results indicate that MPT0G013 abrogates growth factor-induced angiogenesis by up-regulating the antiangiogenic protein TIMP3 in vitro and in vivo, and leads to tumor growth inhibition. Here, PROS1 is linked to neoplasm.